21 Property, plant and equipment

21 Property, plant and equipment

2019

 

 

 

 

 

€ million

Land and buildings

Plant and machinery

Office, computer equipment, vehicles and other

Assets under construction

Total

Gross carrying amount at 1 January

582

885

170

109

1 746

Additions

28

20

22

96

166

Disposals

−28

−88

−34

−2

−152

Transfers from one heading to another

11

18

6

−52

−17

Effect of movements in exchange rates

15

19

2

1

37

Gross carrying amount at 31 December

608

854

166

152

1 780

Accumulated depreciation at 1 January

−294

−518

−127

−2

−941

Depreciation charge for the year

−43

−56

−24

0

−123

Disposals

24

86

32

2

144

Effect of movements in exchange rates

−7

−11

−2

0

−20

Accumulated depreciation at 31 December

−320

−499

−121

0

−940

Net carrying amount at 31 December

288

355

45

152

840

 

 

 

 

 

 

2018

 

 

 

 

 

€ million

Land and buildings

Plant and machinery

Office, computer equipment, vehicles and other

Assets under construction

Total

Gross carrying amount at 1 January

475

768

117

134

1 494

Additions

97

38

49

80

264

Disposals

−2

−9

−3

−1

−15

Transfers from one heading to another

4

73

5

−105

−23

Effect of movements in exchange rates

8

15

2

1

26

Gross carrying amount at 31 December

582

885

170

109

1 746

Accumulated depreciation at 1 January

−250

−464

−105

−2

−821

Depreciation charge for the year

−40

−54

−23

0

−117

Disposals

2

8

2

0

12

Transfers from one heading to another

−2

0

0

0

−2

Effect of movements in exchange rates

−4

−8

−1

0

−13

Accumulated depreciation at 31 December

−294

−518

−127

−2

−941

Net carrying amount at 31 December

288

367

43

107

805

 

 

 

 

 

 

None of the Group property, plant and equipment is subject to restrictions on title nor has it been pledged as security for liabilities.

During 2019, the Group acquired property, plant and equipment totaling € 166 million (2018: € 264 million). These additions include right-of-use assets for an amount of € 40 million (2018: € 140 million), mainly related to the leaseback of the building in Monheim (Germany) and the renewal of the fleet in the U.S. Other additions mainly relate to the new biological production unit and the revamping of a plant on the UCB Braine site (Belgium), upgrade of the biological and manufacturing lines in Bulle (Switzerland), revamping of the office environment and building facilities, IT hardware and other plant and equipment.

During the year, the Group did not recognize any impairment expenses (2018: impairment of € 0 million).

The depreciation charge for the year amounts to € 123 million (2018: € 117 million) and includes the depreciation on the right-of-use assets (€ 39 million).

Capitalized borrowing costs

No borrowing costs were capitalized during 2019 (2018: € 0 million).